Galderma’s $650 million bet on U.S. manufacturing captures Europe’s new investment playbook Markets 22 d ago
Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping Markets 44 d ago also on HD
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences Policy 1 d ago